Skip to Content
SODIUM HYALURONATE OVD

PURE‑HYALSodium Hyaluronate 1.4%, Prefilled Syringe

High-purity cohesive OVD, viscosity exceeding competitors' 1.6%, engineered for superior endothelial protection, stable chamber maintenance, and precise intraocular manipulation in cataract surgery.

1.4%
Sodium Hyaluronate
>1.6%
Viscosity Performance
1 ml PFS
Glass Syringe
Enquire for Pricing Download Brochure
LIQUID GLASS • SODIUM HYALURONATE
PURE-HYAL sodium hyaluronate OVD prefilled syringe
1.4% = >1.6%Viscosity Performance
Cohesive OVDEndothelial Protection
Glass PFSProcedure-Ready
Sodium Hyaluronate 1.4%Cohesive OVDExceeds 1.6% ViscosityEndothelial Protection1 ml Prefilled SyringeSCHOTT GlassOVD Platform1.6% 1.8% 2.0% Coming SoonSodium Hyaluronate 1.4%Cohesive OVDExceeds 1.6% ViscosityEndothelial Protection1 ml Prefilled SyringeSCHOTT GlassOVD Platform1.6% 1.8% 2.0% Coming Soon
THE PURE‑HYAL ADVANTAGE

1.4% that outperforms
competitors' 1.6%.

Through high molecular weight sodium hyaluronate and optimised formulation, PURE‑HYAL 1.4% delivers viscosity that exceeds many 1.6% formulations on the market — while being easier to aspirate and remove.

Typical
1.6%
Competitor
Higher Viscosity
PURE‑HYAL
1.4%
Agaaz Ophthalmics

Lower concentration, higher performance. Better aspiration, easier removal, superior chamber maintenance.

CLINICAL BENEFITS

Engineered for what surgeons
actually need.

PURE‑HYAL combines high-purity sodium hyaluronate with cohesive viscoelastic behaviour for predictable surgical performance.

Endothelial Protection

Cohesive sodium hyaluronate forms a protective coating over the corneal endothelium, reducing mechanical and ultrasonic stress during phacoemulsification.

Stable Anterior Chamber

Maintains depth and clarity during capsulorhexis, lens implantation, and IOL positioning — supporting confident surgical manipulation.

Predictable Handling

Smooth injection and efficient cohesive removal — supporting surgical rhythm without unnecessary resistance or residual fragments.

PURE‑HYAL PLATFORM

A complete viscosity ladder.
One trusted platform.

PURE‑HYAL is expanding — giving surgeons a full range of sodium hyaluronate concentrations from a single platform.

1.4%
Available Now
1.6%
Coming Soon
1.8%
Coming Soon
2.0%
Coming Soon
SPECIFICATIONS

Key parameters at a glance.

Brand
PURE‑HYAL
Sodium Hyaluronate OVD
Active
Sodium Hyaluronate
High molecular weight
Concentration
1.4%
Exceeds 1.6% viscosity
Format
1 ml PFS
SCHOTT glass syringe
PUBLISHED RESEARCH

What the published literature says about sodium hyaluronate ovds and endothelial protection

The clinical case for this product category does not rest on our own material. The studies below are independent, peer-reviewed and indexed in PubMed, and they cover sodium hyaluronate ovds and endothelial protection as a subject. Each entry links to its PubMed record so the primary source can be read in full.

  1. Randomized Controlled TrialProspective randomized clinical trial evaluating efficacy and safety of a new ophthalmic viscosurgical device in patients undergoing cataract surgeryDe Rosa L et al. (2024) · Journal of cataract and refractive surgery · PMID 38711224
  2. Randomized Controlled TrialA Prospective, Randomized, Controlled Clinical Investigation Comparing the Efficacy and Safety of Sodium Hyaluronate-Based Ophthalmical Viscosurgical Devices FIDIAL PLUS and IAL(®)-F in Cataract SurgeryPagnacco C et al. (2024) · Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · PMID 38949891
  3. Randomized Controlled TrialClinical evaluation of a bacterially derived sodium hyaluronate 2.3% ophthalmic viscosurgical deviceChang DH et al. (2019) · Journal of cataract and refractive surgery · PMID 31856991

Independent peer-reviewed publications indexed in PubMed. Listed as clinical background on the molecule and device class; they are not studies of Agaaz products and imply no endorsement.

Further reading

FREQUENTLY ASKED QUESTIONS

Common questions about sodium
hyaluronate OVD and PURE‑HYAL.

What is sodium hyaluronate ophthalmic solution used for?
Sodium hyaluronate ophthalmic solution is a cohesive OVD used during cataract surgery to maintain anterior chamber depth, protect the corneal endothelium, create working space, facilitate IOL implantation, and support tissue manipulation. It is also used in corneal transplantation, glaucoma surgery, and other anterior segment procedures.
How does PURE‑HYAL 1.4% compare to other sodium hyaluronate OVDs?
PURE‑HYAL 1.4% delivers viscosity performance exceeding many competitors' 1.6% formulations through high molecular weight sodium hyaluronate, providing superior chamber maintenance and endothelial coating at a lower concentration, which also means easier aspiration and removal.
What concentrations will PURE‑HYAL be available in?
PURE‑HYAL is currently available in 1.4%. The range is expanding with 1.6%, 1.8%, and 2.0% concentrations launching soon — a complete viscosity ladder from a single trusted platform.
Is PURE‑HYAL available in prefilled syringe format?
Yes. PURE‑HYAL 1.4% is supplied in a 1 ml sterile prefilled SCHOTT glass syringe — procedure-ready, single-use, and designed for consistent delivery.
What is the difference between cohesive and dispersive OVDs?
Cohesive OVDs like sodium hyaluronate stay together as a single mass — excellent for space creation and easy removal. Dispersive OVDs like HPMC fragment into smaller pieces, coating surfaces for better protection during phacoemulsification. PURE‑HYAL combines cohesive benefits with high molecular weight for enhanced protective properties.
Who manufactures PURE‑HYAL?
PURE‑HYAL is manufactured by Agaaz Ophthalmics in Ahmedabad, Gujarat, India — a manufacturer and global exporter of ophthalmic surgical products serving surgeons across 15+ countries.

Start with PURE‑HYAL.

Share your market and volumes. We will support you with product details, documentation, pricing, and a clear path to get started — including early access to upcoming 1.6%, 1.8%, and 2.0% concentrations.

Partner with Agaaz WhatsApp Full Portfolio